Veeva

Cloud-based Software for the Global Life Sciences Industry

Veeva is a leading global provider of industry-specific, cloud-based software solutions for the life sciences industry. Our solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. Veeva operates as a Public Benefit Corporation.

Latest News

May 3, 2023 Veeva to Release Fiscal 2024 First Quarter Results on May 31, 2023
Veeva Systems (NYSE: VEEV) will announce financial results for its first quarter, which ended April 30, 2023, after market close on May 31, 2023. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2024 First Quarter Results Conference Call Date: Wednesday, May 31, 2023 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: https://conferencingportals.com/event/badXudFz Webcast: ir.veeva.com About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a...
Read More
March 1, 2023 Veeva Announces Fourth Quarter and Fiscal Year 2023 Results
Fiscal Year 2023 Total Revenues of $2,155.1M, up 16% Year Over Year;  Q4 Total Revenues of $563.4M, up 16% Year Over Year Fiscal Year 2023 Subscription Services Revenues of $1,733.0M, up 17% Year Over Year;  Q4 Subscription Services Revenues of $460.2M, up 16% Year Over Year  Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and fiscal year ended January 31, 2023. "Our partnership with the industry strengthened in all customer segments and geographies this year as we build a durable, growth business for the long term," said CEO Peter Gassner. "We are early in our very large industry cloud opportunity with an exceptional product innovation and execution engine. It's this combination of opportunity and execution that positions us well for the future." Fiscal 2023 Fourth Quarter Results: Revenues : Total revenues for the fourth quarter were $563.4...
Read More